Citigroup Inc. Has $16.17 Million Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Citigroup Inc. raised its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 27.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 516,680 shares of the company’s stock after buying an additional 110,012 shares during the quarter. Citigroup Inc. owned about 0.30% of Option Care Health worth $16,172,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Price T Rowe Associates Inc. MD lifted its position in Option Care Health by 1.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,760,482 shares of the company’s stock valued at $59,047,000 after acquiring an additional 23,676 shares in the last quarter. Janus Henderson Group PLC boosted its position in shares of Option Care Health by 182.9% during the first quarter. Janus Henderson Group PLC now owns 227,135 shares of the company’s stock worth $7,617,000 after buying an additional 146,837 shares during the period. Tidal Investments LLC grew its holdings in shares of Option Care Health by 74.2% during the first quarter. Tidal Investments LLC now owns 13,460 shares of the company’s stock worth $451,000 after buying an additional 5,733 shares in the last quarter. Harbor Capital Advisors Inc. raised its position in Option Care Health by 317.9% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company’s stock valued at $2,670,000 after buying an additional 73,312 shares during the last quarter. Finally, SG Americas Securities LLC lifted its stake in Option Care Health by 619.3% in the 2nd quarter. SG Americas Securities LLC now owns 60,356 shares of the company’s stock valued at $1,672,000 after acquiring an additional 51,965 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. Truist Financial lowered their price objective on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their price target for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. Finally, JMP Securities upped their target price on Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a report on Monday, September 30th. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, Option Care Health has a consensus rating of “Moderate Buy” and a consensus price target of $30.83.

Option Care Health Stock Up 0.1 %

Shares of OPCH stock opened at $23.76 on Thursday. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $34.63. The stock has a market cap of $4.04 billion, a price-to-earnings ratio of 19.97, a PEG ratio of 2.42 and a beta of 1.32. The firm’s 50-day moving average is $27.16 and its 200-day moving average is $28.96. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.

Insiders Place Their Bets

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the firm’s stock in a transaction on Friday, November 8th. The shares were purchased at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the acquisition, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.